NCT02170636View on ClinicalTrials.gov

Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

March 31, 2002

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS Capsule E

50 mg BIBR 1048 MS

DRUG

BIBR 1048 MS Capsule F

50 mg BIBR 1048 MS

DRUG

BIBR 1048 MS Capsule G

50 mg BIBR 1048 MS

DRUG

BIBR 1048 MS Tablet H

50 mg BIBR 1048 MS

DRUG

BIBR 1048 MS Drinking solution

50 mg BIBR 1048 MS tartaric acid solution

DRUG

Pantoprazole

40 mg Pantoprazole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY